We provide advice to complement the regular
expert consensus on Geovax Labs. Our dynamic recommendation engine utilizes a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time.
This firm dividends can provide a clue to the current value of the stock. Geovax Labs is not expected to issue dividends this year as it is trying to preserve or re-invest any of the funds available for distribution to stakeholders.
Typically, a company's
financial statements are the reports that show the
financial position of the company. There are three main documents that fall into the category of financial statements. These documents include GeoVax Labs income statement, its balance sheet, and the statement of cash flows. Potential GeoVax Labs investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although GeoVax Labs investors may use each financial statement separately, they are all related. The changes in GeoVax Labs's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on GeoVax Labs's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our
technical analysis and
fundamental analysis pages.
The goal of GeoVax Labs
fundamental analysis is to do accurate financial forecasts. There are several possible objectives to fundamental analysis, such as projecting of GeoVax Labs performance into the future periods or doing a reasonable stock valuation. The intrinsic value of GeoVax Labs shares is the value that is considered the true value of the share. If
the intrinsic value of GeoVax is higher than its market price, buying is generally recommended. If it is equal to the market price, it is recommended to hold; and if it is less than the market price, then one should sell all shares GeoVax Labs. Please read more on our
fundamental analysis page.
How effective is GeoVax Labs in utilizing its assets?
GeoVax Labs reports assets on its Balance Sheet. It represents the amount of GeoVax resources that either has an existing economic value or will provide some form of benefits in the future. By effectively utilizing its assets, GeoVax Labs aims to generate revenue, control costs, drive operational efficiency, and enhance profitability. Optimizing asset utilization helps maximize shareholder value and maintain a competitive position in the Biotechnology space. To get a better handle on how balance sheet or income statements item affect GeoVax volatility, please check the breakdown of all its
fundamentals.
Are GeoVax Labs Earnings Expected to grow?
The
future earnings power of GeoVax Labs involves the interaction of many company-specific, industry, and economic forces. Earnings estimates embody investors' opinions of GeoVax Labs factors such as sales growth, product demand, competitive industry environment, profit margins, and cost controls. GeoVax Labs
stock prices adjust as these expectations change or are proven wrong. The main thing to remember is that equities with high expected earnings growth tend to underperform the market because it is usually difficult to meet the market's high expectations. Companies with low earnings expectations tend to do better than expected. Please use our latest analysis of GeoVax
expected earnings.
GeoVax Labs Gross Profit
GeoVax Labs Gross Profit growth is one of the most critical measures in evaluating the company. The Gross Profit growth rate is calculated simply by comparing GeoVax Labs previous period's values with its current period's values. Each time period you're measuring should be of equal lengths the increase or decrease, in a company's Gross Profit between two periods. Here we show GeoVax Labs Gross Profit growth over the last 10 years. Please check GeoVax Labs'
gross profit and other
fundamental indicators for more details.
Another angle On GeoVax Labs
The entity reported the previous year's revenue of 1.22
M. Net Loss for the year was (3.93
M) with loss before overhead, payroll, taxes, and interest of (620.8
K).
Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Geovax Labs has an asset utilization ratio of 91.62 percent. This suggests that the company is making $0.92 for each dollar of assets. An increasing asset utilization means that Geovax Labs is more efficient with each dollar of assets it utilizes for everyday operations.
| Current Assets | 11.04 Million | 98.29 |
| Assets Non Current | 151,326 | 1.35 |
| Goodwill | 40,959.74 | 0.36 |
Over 3 percent rise for Geovax Labs. What does it mean for investors?
Current Risk Adjusted Performance is up to -0.02. Price may slide again. Geovax Labs exhibits very low volatility with skewness of 1.55 and kurtosis of 5.69. However, we advise investors to further study Geovax Labs technical indicators to make sure all market info is available and is reliable. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Geovax Labs' stock risk against market volatility during both bullying and bearish trends. The higher level of volatility that comes with bear markets can directly impact Geovax Labs' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.
Geovax Labs Implied Volatility
Geovax Labs' implied volatility exposes the market's sentiment of Geovax Labs stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Geovax Labs' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Geovax Labs stock will not fluctuate a lot when Geovax Labs' options are near their expiration.
The Current Takeaway on Geovax Labs Investment
While many of the other players under the biotechnology industry are still a bit expensive, Geovax Labs may offer a potential longer-term growth to investors. While some investors may not share our view we believe that the current risk-reward utility is not appealing enough to do any trading. Please use our equity advice module to run different scenarios to ensure your current risk level and investment horizon are fully reflective of your current investing preferences in regards to Geovax Labs.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectEditorial Staff
Raphi Shpitalnik is a Junior Member of Macroaxis Editorial Board. Raphael is a young entrepreneur who joined Macroaxis on a part-time basis at the beginning of the pandemic and eventually acquired a real taste for investing and fintech. He likes to analyze different equity instruments across a wide range of industries, focusing primarily on consumer products, sports, fintech, cannabis, and AI.
View Profile This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Raphi Shpitalnik do not own shares of GeoVax Labs. Please refer to our
Terms of Use for any information regarding our disclosure principles.
Would you like to provide feedback on the content of this article?
You can get in touch with us directly or send us a quick note via email to
editors@macroaxis.com